All News

Feet, foot

Pre-clinical RA: starting off the wrong foot

d Aurelie Najm, MD, PhD

Patients with clinically suspect arthralgia can represent a challenge for clinicians, in a sense that there are not yet reliable markers to predict evolution to clinical RA nor enough evidence to support routine prescription of conventional synthetic DMARDS or biologic treatments in this setting.

Read Article
obesity.knee_.arthritis.jpg

Genes and Obesity Tied to Higher Gout Risk in Women

d Jack Cush, MD

Excess adiposity and genetic predisposition both contributed to risk of gout among U.S. women, with the risks being highest when both factors are present, a large prospective study found.

Read Article
switch.jpg

Monitoring Infliximab Drug Levels Improves Efficacy

d Robert Chao, MD

Should we start considering therapeutic drug monitoring when prescribing TNFi for treatment of our rheumatologic conditions?

Read Article
nobel-prize-1356450__180.jpg

Pain is the Focus of the 2021 Nobel Prize in Medicine

d Jack Cush, MD

The 2021 Nobel Prize in Medicine and Physiology was jointly awarded to Drs.

Read Article
Telemedicine.MD.Computer.phone (keep)

Telehealth Diet and Exercise Benefits Knee Osteoarthritis

d Jack Cush, MD

Annals of Internal Medicine has reported the results of a randomized clinical trial showing that telehealth-delivered exercise and diet programs improved pain and function in knee osteoarthritis patients who were overweight.  While both were beneficial, exercise had a greater effect than die

Read Article
Zoom Fatigue is real. Study shows fatigue is from being on-cam that triggers self-presentation - the needs to monitor how you look to others; more common in women. Suggest: reduce monitor/image size & Turn off Self view (avoid self evaluation) https://t.co/KYi8bMKURy https://t.co/8fUqdpe6ia

Links:

Dr. John Cush RheumNow ( View Tweet)
BMS has announced they have filed a new drug application with the FDA and EMA for Deucravacitinib, a TYK2 inhibitor, to treat adults with moderate to severe plaque psoriasis. (w/ a PDUFA goal date of 9/10/2022) https://t.co/w5YmRYdXm4

Links:

Dr. John Cush RheumNow ( View Tweet)

Improving Our Everyday RA Practice https://t.co/eGPRMBGFjh https://t.co/y49x8MX4dK

Links:

Dr. John Cush RheumNow ( View Tweet)
The Gift of Gab: "RHEUM" Dr. Eric Dein interviews Professor Zeide and Dr. Jason Liebowitz about a lively ACR21 talk called, "The Gift of Gab," which guided attendees on how to improve their communications. https://t.co/fWOETKqQeP https://t.co/5b5rXzEAaQ

Links:

Dr. John Cush RheumNow ( View Tweet)
Cognitive Function and Rheumatoid Arthritis: Dr. Akhil Sood Interviews Dr. Elena Myasoedova https://t.co/k3SBwEg0WH https://t.co/1eEBUQdMAa

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow Live will be held in person AND virtually on March 19 and 20 in Irving, TX. Register Today! https://t.co/ntNiWwjkFU https://t.co/NfFHgVxXa2

Links:

Dr. John Cush RheumNow ( View Tweet)
Risks associated with mortality in VEXAS https://t.co/6FIzZjlB0c https://t.co/YVoKOymWCX

Links:

Dr. John Cush RheumNow ( View Tweet)
#TBT #ACR21 Nice talk re:controversies in Behcets Cutaneous dx: $$ favors colchicine; apremilast a nice option for refractory dx, AZA as well Uveitis? TNF for panuveitis "1st choice" but 1/2 respond to csDMARDs as well TCZ promising alternative; I have used w/some benefit https://t.co/XsCvhCBjS5
Mike Putman EBRheum ( View Tweet)
What are the advantages and disadvantages of #ultrasound-guided intra-articular injections? Check out this slide👇from Lt.Col/Dr. Arjun's lecture: #iracon21 #IRACON2021 @2021Iracon @APLAR_org #mskus #rheumatology https://t.co/mhq9OgBk7a
sheila RHEUMarampa ( View Tweet)
JAK Safety -- The Lowdown on Infection https://t.co/Mi6EDqP7RE https://t.co/ZVZaXHGHIk

Links:

Dr. John Cush RheumNow ( View Tweet)
Rheumatology Roundup! Drs. Cush and Kavanaugh convene for their annual impromptu review of some of the best and more interesting abstracts presented at ACR 2021. https://t.co/rp7TT6nTMA https://t.co/Zk73M6OUqO

Links:

Dr. John Cush RheumNow ( View Tweet)
Closing a Chapter: Interview with Dr. David Karp, 84th ACR President 2020-2021 https://t.co/GuE9NdkHlN https://t.co/8e2cUO7Qs3

Links:

Dr. John Cush RheumNow ( View Tweet)
Tofacitinib and Malignancy Risk Dr. David Liew interviews Dr. Seoyoung Kim at the ACR21 annual meeting. https://t.co/vaoxuy6u5j https://t.co/t3kpMEqy9O

Links:

Dr. John Cush RheumNow ( View Tweet)
Spondyloarthritis Panel Discussion: ACR21 Meeting https://t.co/lR6zPHKpOo https://t.co/JGsloJUD2t

Links:

Dr. John Cush RheumNow ( View Tweet)
CDC and the ICD-10 Coordination and Maintenance Committee has assigned a diagnostic code for non-radiographic axial spondyloarthritis (nr-axSpA) == M45.A

Dr. John Cush RheumNow ( View Tweet)

×